Health Care & Life Sciences » Pharmaceuticals | Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc. | Ownership

Companies that own Syndax Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Management Co. LLP
3,346,356
13.55%
-111,356
0.01%
06/30/2018
BlackRock Fund Advisors
1,258,996
5.09%
357,402
0%
06/30/2018
BVF Partners LP
1,233,618
4.99%
-2,000,000
0.65%
06/30/2018
The Vanguard Group, Inc.
742,889
3.01%
22,196
0%
06/30/2018
Fidelity Management & Research Co.
560,202
2.27%
0
0%
06/30/2018
Dimensional Fund Advisors LP
558,725
2.25%
161,146
0%
06/30/2018
OrbiMed Advisors LLC
437,000
1.77%
0
0.04%
06/30/2018
683 Capital Management LLC
375,000
1.52%
91,770
0.33%
06/30/2018
Alyeska Investment Group LP
338,789
1.37%
10,834
0.03%
06/30/2018
BlackRock Advisors LLC
320,363
1.3%
8,661
0%
06/30/2018

About Syndax Pharmaceuticals

View Profile
Address
35 Gatehouse Drive
Waltham Massachusetts 02451
United States
Employees -
Website http://www.syndax.com
Updated 07/08/2019
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.